March 8-10, 2017
US Bioassay Conference (BEBPA) 2017
Sheraton Fisherman's Wharf • San Francisco, CA
DiscoverX booth in exhibit area
DiscoverX Talk—Monday, March 9, 4:30–5 p.m., Bioassays for Biosimilar development section
Developing, Optimizing & Qualifying Bioassays for Biosimilars, Biobetters and Innovator Drugs
Poster Presentations
- Development & Evaluation of A Novel Bioassay for Denosumab Activity
- Novel, Improved Cell-based Assays to Enable Immunotherapy Drug Development for Checkpoint Receptors
- Ready-to-Use Potency Assays For Bevacizumab, Aflibercept and Ranibizumab
- Qualified, Fit-for-Purpose Bioassays for Liraglutide and Exenatide as Frozen Ready-to-Use Cells
Learn more
|